In-Vitro Diagnostics Market, 2023

Dublin, June 23, 2017 -- Research and Markets has announced the addition of the "In-Vitro Diagnostics Global market - Forecast to 2023" report to their offering.

In-vitro diagnostic is a process in which reagents, instruments, and systems are intended for the diagnosis of disease or other conditions or for determining the state of health, to cure, mitigate, treat, or prevent disease. This includes reagents, calibrators, control materials, specimen receptacles, software, and related instruments.

The in-vitro diagnostics market is segmented into Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Rapid tests, Enzyme-Linked Immunospot (Elispot) Assay and others are some of the immunoassay techniques in the IVD market. Basic Metabolic Panel, Electrolyte Panel, liver Panel, Lipid Profile, Renal Profile and Thyroid function panel and specialty chemical tests are some of the clinical chemistry technologies. Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Microarray, Hybridization, DNA Sequencing & Next-Generation Sequencing and others are some of the molecular diagnostics market. Along with these, clinical microbiology, hematology, coagulation and hemostasis and others are the type of the IVD technologies in the market.

Among technologies in in-vitro diagnostics market, immunochemistry techniques accounted for the largest share in 2016 growing at mid range single digit CAGR and molecular diagnostics is expected to grow at high single digit CAGR from 2016-2023.

Growing healthcare expenditure in the emerging markets, strong demand for technologically advanced testing methods for disease diagnosis, increasing adaptation of point of care testing, increasing incidences of chronic lifestyle diseases are some of the important driving factors for this market. It is also seen that there is an increase in the number of clinical laboratories with improved infrastructure in many developed countries which could further push the diagnostics market in these regions. However, Lack of proper reimbursement policies in the developing countries and stringent regulatory framework are the main factors hampering the growth of the IVD market.

Key Topics Covered:

1 Executive Summary

2 Introduction

3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers and Opportunities
3.3.1.1 Growing Incidence of Chronic and Infectious Diseases
3.3.1.2 Increasing Adoption of Point-Of-Care Testing
3.3.1.3 Emergence of Next Generation Molecular Diagnostics
3.3.1.4 Growing Awareness of Companion Diagnostics and Personalized Medicine
3.3.1.5 Emergence of Minimally Invasive and Non Invasive Diagnostics
3.3.1.6 Rising Number of Clia-Waived Ivd Tests
3.3.2 Restraints & Threats
3.3.2.1 Rising Incidence of Product Recalls
3.3.2.2 Lack of Skilled Laboratory Technicians in Developing Nations
3.3.2.3 Inadequate Reimbursement
3.3.2.4 Stringent Regulatory Framework
3.4 Porter's Five Force Analysis

4 In-Vitro Diagnostics Global Market, by Technology
4.1 Introduction
4.2 Immunochemistry
4.2.1 Enzyme-Linked Immunosorbent Assays (ELISA)
4.2.1.1 Chemiluminescence Immunoassays (CLIAS)
4.2.1.2 Fluorescence Immunoassays (FIAS)
4.2.1.3 Colorimetric Immunoassays (CIC)
4.2.2 Radioimmunoassay (RIA)
4.2.3 Enzyme-Linked Immunospot (ELIspot) Assay
4.2.4 Rapid Tests
4.2.5 Other Immunoassay Techniques
4.3 Clinical Chemistry
4.3.1 Basic Metabolic Profile
4.3.2 Electrolyte Panel
4.3.3 Liver Panel
4.3.4 Lipid Panel
4.3.5 Renal Panel
4.3.6 Thyroid Function Panel
4.3.7 Specialty Chemical Tests
4.4 Molecular Diagnostics
4.4.1 PCR (Polymerase Chain Reaction)
4.4.2 Isothermal Nucleic Acid Amplification Technology
4.4.3 Microarray
4.4.4 Hybridization
4.4.5 Dna Sequencing and Next Generation Sequencing (NGS)
4.4.6 Other MDX Technologies
4.5 Clinical Microbiology
4.6 Hematology
4.7 Coagulation and Hemostasis
4.8 Other IVD Technologies

5 In-Vitro Diagnostics Global Market, by Application
5.1 Introduction
5.2 Oncology
5.3 Diabetes
5.4 Infectious Diseases
5.5 Genetic Testing
5.6 Cardiology
5.7 Autoimmune Diseases
5.8 Drug Testing
5.9 Nephrology
5.10 Transplantation Technology
5.11 Others

6 In-Vitro Diagnostics Global Market, by Product
6.1 Introduction
6.2 Instruments
6.3 Reagents
6.4 Software and Services

7 In-Vitro Diagnostics Market, by Sample Type
7.1 Introduction
7.2 Blood
7.3 Saliva
7.4 Urine
7.5 Others

8 In-Vitro Diagnostics Global Market, by End User
8.1 Introduction
8.2 Diagnostic Laboratories
8.3 Hospitals
8.4 Academic & Research Centres
8.5 Home Care
8.6 Other End Users

9 Regional Market Analysis

10 Company Developments
10.1 Introduction
10.1.1 Regulatory Approval as a Major Growth Strategy of In-Vitro Diagnostics Market Players
10.2 Approval
10.3 New Product Launch
10.4 Agreements, Parterner Ships, Collaborations & Joint Ventures
10.5 Mergers and Acquisitions
10.6 Business Expansion

11 Company Profiles

• Abbott Laboratories (U.S.)
• Becton Dickinson (U.S.)
• Bio-Rad laboratories (U.S.)
• BioMerieux (France)
• Danaher Corporation (U.S.)
• Hoffmann-la Roche (Switzerland)
• Siemens AG (Germany)
• Carlyle Group (Ortho Clinical Diagnostics) (U.S.)
• Johnson and Johnson (U.S.)
• Sysmex Corporation (Japan)
• ThermoFisher Scientific (U.S.)
• Hologic Inc (U.S.).

For more information about this report visit https://www.researchandmarkets.com/research/cgdj2s/invitro

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: In Vitro Diagnostics